ScholarIQanswers from OpenAlex & ORCID
Jesús G. Berdeja
ResearcherPublications, citations & collaboration network
Jesús G. Berdeja is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jesús G. Berdeja have?
ScholarIQindexed works
Jesús G. Berdeja has 534 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jesús G. Berdeja have?
ScholarIQcitation count
Jesús G. Berdeja has 19,178 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jesús G. Berdeja?
ScholarIQh-index
Jesús G. Berdeja has an h-index of 60 in OpenAlex.
What is the i10-index of Jesús G. Berdeja?
ScholarIQi10-index
Jesús G. Berdeja has an i10-index of 197 in OpenAlex.
What is the ORCID of Jesús G. Berdeja?
ScholarIQorcid
The ORCID for Jesús G. Berdeja is on the source record.
What is the OpenAlex record for Jesús G. Berdeja?
ScholarIQopenalex
The OpenAlex for Jesús G. Berdeja is on the source record.
What are the most-cited papers on Jesús G. Berdeja?
ScholarIQmost cited works
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi, Larry D. Anderson, Nina Shah, Deepu Madduri, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David S. Siegel, Albert Oriol, Philippe Moreau, Ibrahim Yakoub‐Agha, Michel Delforge, Michèle Cavo, Hermann Einsele, Hartmut Goldschmidt, Katja Weisel, Alessandro Rambaldi, Donna Reece, Fabio Petrocca, Monica Massaro, Jamie N. Connarn, Shari M. Kaiser, Payal Patel, Liping Huang, Timothy Campbell, Kristen Hege, Jesús F. San Miguel
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje, Jesús G. Berdeja, Yi Lin, David S. Siegel, Sundar Jagannath, Deepu Madduri, Michaela Liedtke, Jacalyn Rosenblatt, Marcela V. Maus, Ashley Turka, Lyh-Ping Lam, Richard A. Morgan, Kevin M. Friedman, Monica Massaro, Julie Wang, Greg Russotti, Zhihong Yang, Timothy Campbell, Kristen Hege, Fabio Petrocca, M. Travis Quigley, Nikhil C. Munshi, James N. Kochenderfer
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani, Andrzej Jakubowiak, Mounzer Agha, Adam D. Cohen, A. Keith Stewart, Parameswaran Hari, Myo Htut, Alexander M. Lesokhin, Abhinav Deol, Nikhil C. Munshi, Elizabeth O’Donnell, David Avigan, Indrajeet Singh, Enrique Zudaire, Tzu‐Min Yeh, Alicia J. Allred, Yunsi Olyslager, Arnob Banerjee, Carolyn C. Jackson, Jenna D Goldberg, Jordan M. Schecter, William Deraedt, Sen Hong Zhuang, Jeffrey R. Infante, Dong Geng, Xiaoling Wu, Marlene J. Carrasco-Alfonso, Muhammad Akram, Farah Hossain, Syed Rizvi, Frank Fan, Yi Lin, Thomas G. Martin, Sundar Jagannath
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
Paula Rodríguez‐Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina K. Patel, Michèle Cavo, Ajay K. Nooka, Salomon Manier, Natalie S. Callander, Luciano J. Costa, Ravi Vij, Nizar J. Bahlis, Philippe Moreau, Scott R. Solomon, Michel Delforge, Jesús G. Berdeja, Anna Truppel-Hartmann, Zhihong Yang, Linda Favre‐Kontula, Fan Wu, Julia Piasecki, Mark Cook, Sergio Giralt
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
Ajai Chari, Monique C. Minnema, Jesús G. Berdeja, Albert Oriol, Niels W.C.J. van de Donk, Paula Rodríguez‐Otero, Elham Askari, María‐Victoria Mateos, Luciano J. Costa, Jo Caers, Raluca Verona, Suzette Girgis, Shiyi Yang, Rachel B. Goldsmith, Xiang Yao, Kodandaram Pillarisetti, Brandi Hilder, Jeffery S. Russell, Jenna D. Goldberg, Amrita Krishnan